BOULDER, Colo., Jan. 3, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)
Event: | Annual J.P. Morgan Healthcare Conference |
Presenter: | Ron Squarer, Chief Executive Officer, Array BioPharma |
Date: | Tuesday, January 14, 2014 |
Time: | 4:00 p.m. Pacific Time |
Location: | Westin St. Francis Hotel, San Francisco |
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520), for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and MEK162 (Novartis). For more information on Array, please go to www.arraybiopharma.com
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
SOURCE Array BioPharma Inc.
Help employers find you! Check out all the jobs and post your resume.
